Literature DB >> 33142205

Ex-vivo biomechanics of repaired rat intervertebral discs using genipin crosslinked fibrin adhesive hydrogel.

Kengo Fujii1, Alon Lai2, Nimrod Korda2, Warren W Hom2, Thomas W Evashwick-Rogler3, Philip Nasser2, Andrew C Hecht2, James C Iatridis4.   

Abstract

Microdiscectomy is the current standard surgical treatment for intervertebral disc (IVD) herniation, however annulus fibrosus (AF) defects remain unrepaired which can alter IVD biomechanical properties and lead to reherniation, IVD degeneration and recurrent back pain. Genipin-crosslinked fibrin (FibGen) hydrogel is an injectable AF sealant previously shown to partially restore IVD motion segment biomechanical properties. A small animal model of herniation and repair is needed to evaluate repair potential for early-stage screening of IVD repair strategies prior to more costly large animal and eventual human studies. This study developed an ex-vivo rat caudal IVD herniation model and characterized torsional, axial tension-compression and stress relaxation biomechanical properties before and after herniation injury with or without repair using FibGen. Injury group involved an annular defect followed by removal of nucleus pulposus tissue to simulate a severe herniation while Repaired group involved FibGen injection. Injury significantly altered axial range of motion, neutral zone, torsional stiffness, torque range and stress-relaxation biomechanical parameters compared to Intact. FibGen repair restored the stress-relaxation parameters including effective hydraulic permeability indicating it effectively sealed the IVD defect, and there was a trend for improved tensile stiffness and axial neutral zone length. This study demonstrated a model for studying IVD herniation injury and repair strategies using rat caudal IVDs ex-vivo and demonstrated FibGen sealed IVDs to restore water retention and IVD pressurization. This ex-vivo small animal model may be modified for future in-vivo studies to screen IVD repair strategies using FibGen and other IVD repair biomaterials as an augment to additional large animal and human IVD testing.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Annulus fibrosus repair; Biomechanics; Fibrin genipin; Intervertebral disc; Rat

Year:  2020        PMID: 33142205      PMCID: PMC7736236          DOI: 10.1016/j.jbiomech.2020.110100

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  5 in total

Review 1.  Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration.

Authors:  Yizhong Peng; Xiangcheng Qing; Hongyang Shu; Shuo Tian; Wenbo Yang; Songfeng Chen; Hui Lin; Xiao Lv; Lei Zhao; Xi Chen; Feifei Pu; Donghua Huang; Xu Cao; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-06-28

2.  Ex vivo biomechanical evaluation of Acute lumbar endplate injury and comparison to annulus fibrosus injury in a rat model.

Authors:  Dalin Wang; Alon Lai; Jennifer Gansau; Philip Nasser; Yunsoo Lee; Damien M Laudier; James C Iatridis
Journal:  J Mech Behav Biomed Mater       Date:  2022-04-14

3.  Whether Out-of-Bed Activity Restriction in the Early Postoperative Period of PELD Is Beneficial to Therapeutic Efficacy or Reduce Recurrence.

Authors:  Xiao Liang; Yexin Wang; Yaosheng Yue; Yanpeng Li; Chunyang Meng
Journal:  Front Surg       Date:  2022-05-09

4.  Genipin Cross-Linked Decellularized Nucleus Pulposus Hydrogel-Like Cell Delivery System Induces Differentiation of ADSCs and Retards Intervertebral Disc Degeneration.

Authors:  Lei Yu; Yi Liu; Jianxin Wu; Shuang Wang; Jiangming Yu; Weiheng Wang; Xiaojian Ye
Journal:  Front Bioeng Biotechnol       Date:  2021-12-23

Review 5.  From Mechanobiology to Mechanical Repair Strategies: A Bibliometric Analysis of Biomechanical Studies of Intervertebral Discs.

Authors:  Dian Zhang; Minshan Feng; Wei Liu; Jie Yu; Xu Wei; Kexin Yang; Jiawen Zhan; Wei Peng; Mingyi Luo; Tao Han; Zhefeng Jin; He Yin; Kai Sun; Xunlu Yin; Liguo Zhu
Journal:  J Pain Res       Date:  2022-07-28       Impact factor: 2.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.